Skip to content

Huntington’s disease: An overview

A look at the presentation and pathophysiology of Huntington’s disease and the latest national and international research approaches to developing therapies Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder causing movement, cognitive and psychiatric deterioration leading to progressive disability and eventual death. The genetic mutation was identified in 1993 as an expanded CAG repeat…

Read More

Multiple sclerosis: Diagnosis, management and impact of Covid-19

MS overview MS is a neurological condition caused by inflammation affecting the brain and spinal cord. It is a demyelinating disease, which pathologically is characterised by damage to the myelin. The exact aetiology remains unclear although a combination of genetic and environmental factors such as Epstein-Barr virus (EBV) exposure, vitamin D and smoking play a…

Read More

Migraine and healthcare professionals: The European picture

Lack of education and training for clinicians is a key issue impeding proper management of migraine On 22 September, the European Migraine and Headache Alliance (EMHA) organised ‘The Missing Lesson’ webinar to raise awareness about migraine at EU level and kick-start its EU policy advocacy campaign to make migraine a European health priority. The webinar…

Read More

Telemedicine in rare neurological diseases

European Reference Networks are virtual networks that connect healthcare professionals around Europe with expertise in rare diseases to help patients We are living in unprecedented times. If I had been told this time last year that I would be seeing and doing clinical examination, even if limited in some cases, virtually on a regular basis…

Read More

Neurological manifestations of Covid-19

56th Annual Irish Neurological Association Meeting, 1-2 October 2020 Prof Patrick Mallon, Professor of Microbial Diseases in the UCD School of Medicine and Consultant in Infectious Diseases in St Vincent’s University Hospital, spoke at the 56th Annual Irish Neurological Association Meeting about the neurological manifestations arising from SARS-CoV-2 infection. “There are a lot of knowledge…

Read More

Socioeconomic deprivation related to increased incidences of epilepsy in Cork

56th Annual Irish Neurological Association Meeting, 1-2 October 2020 Dr Eimer Maloney, Cork University Hospital, reported her findings in relation to the impact of socioeconomic deprivation on the incidence of epilepsy in Cork. For this presentation, she was awarded first place in both the Harold Miller Prize for best overall presentation and the John Kirker…

Read More

VP shunt silicone allergy: A case study

56th Annual Irish Neurological Association Meeting, 1-2 October 2020 Dr Martin Leer, Royal Victoria Hospital Belfast, spoke of his experience with an 18-year-old female patient with a background of benign external hydrocephalus – a build-up of cerebrospinal fluid (CSF) in the brain. Ventriculoperitoneal (VP) shunting is the most common neurosurgical procedure performed for the management…

Read More

New EEG referral form: Potential to increase efficiency and save money

56th Annual Irish Neurological Association Meeting, 1-2 October 2020 Dr Emily O’Brien, St Vincent’s University Hospital, presented the results of an audit investigating the efficiency of the inpatient electroencephalogram (EEG) service in St Vincent’s University Hospital from October 2019 to April 2020 at the conference. A total of 130 inpatient referrals were included in this…

Read More

Multiple sclerosis- new and existing therapies CPD Module

2 CPD Hours Authors Dr Maria Gaughan, Newman Fellow in Neurology, St. Vincent’s University Hospital This module addresses the diagnosis and management of multiple sclerosis. Presenting symptoms, the 2017 McDonald criteria and the wide range of treatment options, their applications and risks are also discussed. The module also addresses pregnancy and MS. To earn CME…

Read More

Management of MS relapses discussed

Relapses associated with multiple sclerosis (MS) should not be relied upon to monitor disease activity, according to a presentation at the recent Neurology Update meeting. Consultant Neurologist in the Royal Victoria Hospital (RVH), Belfast, Dr Stella Hughes conveyed this message during her talk, which was entitled “MS Relapses – Dos and Don’ts”. While she said…

Read More
Scroll To Top